Barely Significant
← all excerpts

The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis.

Transl Pediatr · 2021 · PMC8193009 · PMID 34189087

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

nearly reached a significant levelP=0.07so close (0.05 < p ≤ 0.1)
Subgroup analysis for using IFX in the North American population nearly reached a significant level compared with IVIG therapy on the treatment response (OR, 2.75; 95% CI: 0.92–8.27; P=0.07; random-effects model), and there was medium heterogeneity in the subset analysis (Chi 2 =6.48; df =3; I 2 =54%) ( Figure 3C ).

also in 3 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.